Cerus (CERS) News Today
CERS rose 5.15% in the 10 minutes after this headline crossed at 16:00:00 ET on Monday, Nov 2:
Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells
Price 2.33 two minutes before the headline, 2.45 10 minutes after it.
Latest headline on this page:
Ask ChatGPT about CERSAsk Claude about CERSConnect MoveSurge to your assistant
1 headline on Cerus appeared in our news feed in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was +5.15% over 10 minutes on CERS, after the headline at Nov 2, 16:00:00 ET.
What moved CERS — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Nov 2, 16:00:00 ET | Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells | +14.59% | +5.15% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.